Omeros (OMER)
(Delayed Data from NSDQ)
$3.32 USD
-0.04 (-1.04%)
Updated May 28, 2024 04:00 PM ET
After-Market: $3.32 +0.01 (0.15%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Omeros Corporation [OMER]
Reports for Purchase
Showing records 421 - 423 ( 423 total )
Company: Omeros Corporation
Industry: Medical - Products
Q2 Financials Uneventful; However, In Our View Phase 3 Clinical Data Release In Q4 Could Result In Significant Upside.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Omeros Corporation
Industry: Medical - Products
Q1 Financials Uneventful; However, We Believe Clinical Data In H2 2010 Could Result In Significant Upside.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Omeros Corporation
Industry: Medical - Products
2009 Financials Uneventful; However, We Believe Additional Clinical Data In 2010 Could Result In Significant Upside
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L